Health First Europe organised this meeting of the European Parliamentary Interest Group on Innovation in Health and Social Care to discuss tackling antibiotic resistance and healthcare-associated infections.
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
A team of multidisciplinary experts, including ECDC staff and an expert from Norway, visited Romania between 4 and 7 July to discuss aspects related to the detection, surveillance, prevention and control of healthcare-associated infections (HAIs), together with staff at the Ministry of Health, the National Institute for Public Health and other Romanian stakeholders. This was an exploratory visit following a request for support made by the Romanian Minister of Health to tackle the challenges that the country was currently facing in this area.
The main objective of this course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
Emerging diseases and outbreak investigations, whole genome sequencing-based surveillance and public health risks related to animal and food imports to the EU/EEA were some of the topics under discussion during the Food- and Waterborne Diseases and Zoonoses Network meeting.
The European Parliament Committee on the Environment, Public Health and Food Safety held a meeting with the European Commission, ECDC and EFSA on the risks posed by food-borne Campylobacter bacteria and the possible control options.
Location:Brussels, Belgium
Organized by:European Parliament Committee on the Environment, Public Health and Food Safety
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.